Cytokine Signaling in Skeletal Muscle Wasting

Trends Endocrinol Metab. 2016 May;27(5):335-347. doi: 10.1016/j.tem.2016.03.002. Epub 2016 Mar 26.

Abstract

Skeletal muscle wasting occurs in a variety of diseases including diabetes, cancer, Crohn's disease, chronic obstructive pulmonary disease (COPD), disuse, and denervation. Tumor necrosis factor α (TNF-α) is involved in mediating the wasting effect. To date, a causal relationship between TNF-α signaling and muscle wasting has been established in animal models. However, results from clinical trials are conflicting. This is partly due to the fact that other factors such as TNF-like weak inducer of apoptosis (TWEAK) and interleukin 6 (IL-6) are also involved in skeletal muscle wasting. Because muscle wasting is often associated with physical inactivity and reduced food intake, therapeutic interventions will be most effective when multiple approaches are used in conjunction with nutritional support and exercise.

Keywords: TNF-α; TRAF6; TWEAK; muscle wasting.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokine TWEAK / metabolism
  • Humans
  • Interleukin-6 / metabolism
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology*
  • Muscular Atrophy / genetics
  • Muscular Atrophy / metabolism*
  • Signal Transduction / genetics
  • Signal Transduction / physiology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cytokine TWEAK
  • Interleukin-6
  • Tumor Necrosis Factor-alpha